Stock Movers on FDA Decision (SNTS, GERN, GSK, SNY)

Santarus, Inc. (Nasdaq: SNTS) rose 26% to $2.79 on heavy volume after S2 Therapeutics, Inc. and VeroScience LLC announce today that they have entered into an agreement which would give Santarus exclusive rights to manufacture and commercialize CYCLOSET tabs in the U.S.

You can Subscribe to these Free Stock Alerts by visiting:  http://www.PennyStockPickReport.com

CYCLOSET, approved by the U.S. FDA, is a drug that, in combination with diet and exercise, aims to improve glycemic control in adults with type 2 diabetes mellitus both as mono-therapy and in combination with other oral antidiabetic agents.

Geron Corporation (Nasdaq: GERN) rose 5.52% to $5.16 on heavy volume Sierra Sciences, in collaboration with TA Sciences, Geron Corporation (Nasdaq: GERN), PhysioAge, and the Spanish National Cancer Research Center (CNIO), announced today that they have discovered the first compound that activates the enzyme telomerase in the human body. Telomerase is a prerequesite that could arrest or reverse the aging process in humans.

GlaxoSmithKline (NYSE: GSK) rose 0.54% to $39.31.after the company and Genmab A/S announced today that they have commenced a Phase III studying ofatumumab in rituximab refractory patients with indolent B-cell non-Hodgkin's Lymphoma.

A total of 338 patients were enrolled in the study, and randomized to receive either ofatumumab in addition to bendamustine or bendamustine alone.

You can Subscribe to these Free Stock Alerts by visiting:  http://www.PennyStockPickReport.com

Sanofi-aventis (NYSE: SNY) rose 2% to $30.85 after Sanofi-aventis (NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announces that the Phase 3 VELOUR clinical will continue to completion without any modifications.

The Phase 3 examines aflibercept (VEGF Trap) in patients with metastatic colorectal cancer (mCRC).

Questcor (Nasdaq: QCOR) says FDA to require more time for HP Acthar review, specifically to finalize the wording on the label.

About http://www.PennyStockPickReport.com

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, nasdaq penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.